Balaji Amines Limited · NSE:BALAMINES
Balaji Amines — Q3 FY2025 Earnings Presentation
44 slides from Balaji Amines's earnings presentation, Feb 14, 2025
Slide 1: Exchange intimation letter for Q3FY25 investor presentation
14th February, 2025 To, The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Ban
Slide 2: Investor Presentation – February 2025
Investor Presentation – February 2025
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securiti
Slide 4: Results Highlights
Results Highlights About Us Financial Performance Moving towards Growth Prospects
Slide 5: 9MFY25: Financial Highlights
9MFY25 : Financial Highlights Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT Margin Consolidated -14% -26% -20% 1,248 247 160 20% 18% 1,070 198 118 13% 11% 9MFY24 9MFY25 9MFY24 9MFY25 9MFY24 9MFY25 9MFY24 9MFY25 Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT
Slide 6: Q3FY25: Financial Highlights
Q3FY25 : Financial Highlights Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT Margin Consolidated -18% -35% -45% 392 83 56 21% 20% 356 70 321 17% 41 14% 54 12% 31 10% Q3FY24 Q2FY25 Q3FY25 Q3FY24 Q2FY25 Q3FY25 Q3FY24 Q2FY25 Q3FY25 Q3FY24 Q2FY25 Q3FY25 Revenue (Rs. Crore) EBITDA (R
Slide 7: Q3 FY25 - Consolidated Performance Highlights
Q3 FY25 - Consolidated Performance Highlights Revenue from Operations for 9MFY25 stood at ₹ 1,070 crore, as compared to ₹ 1,248 crore in 9MFY24. Total volumes stood at 78,516 MT for 9MFY25 as against 81,336 MT in 9MFY24. For 9MFY25, • Amines volumes stood at 22,532 MT • Amines Derivatives volumes st
Slide 8: New Project Highlights (1/2)
New Project Highlights (1/2) Electronic Grade DMC : We are adding additional equipment to be integrated in the existing DMC/PG plant. Most of this equipment was received at site and the plant is likely to be commissioned by the end of March 2025 Propylene Glycol Pharma Grade : We are adding addi
Slide 9: New Projects Highlights (2/2)
New Projects Highlights (2/2) New Projects: o The company is proposing to set up a plant for manufacture of N-(N-Butyl) Thiophosphoric Triamide(NBPT) with a capacity of 2500 TPA which will be taken up next Financial Year o The company is proposing to set up an ACN plant with a capacity of 60 MT/Day
Slide 10: Phase-2 & 3 Expansion Plans at our 90-acre Greenfield Project (Unit IV)
Phase -2 & 3 Expansion Plans at our 90-acre Greenfield Project (Unit IV) EXECUTED ON SCHEDULE EXECUTED ON SCHEDULE IN PROGRESS n-Butylamine Methylamines Dimethyl Ether • We have undertaken capex for a new product, • Market Leader in Methylamines production in • Dimethyl Ether (DME) with a Capacity o
Slide 11: Standalone Statement of Profit & Loss
Standalone Statement of Profit & Loss Particulars (in Rs. Crore) Q3FY25 Q2FY25 Q-o-Q 9MFY25 9MFY24 Y-o-Y Total Revenue 305 326 -7% 969 986 -2% Raw Material 164 176 527 566 Employee expense 17 18 52 50 Other expenses 66 68 204 197 EBITDA 57 64 -11% 185 173 7% EBITDA Margin 19% 20% 19% 18% Depreciatio
Slide 12: Consolidated Statement of Profit & Loss
Consolidated Statement of Profit & Loss Particulars (in Rs. Crore) Q3FY25 Q2FY25 Q-o-Q 9MFY25 9MFY24 Y-o-Y Total Revenue 321 356 -10% 1,070 1,248 -14% Raw Material 178 188 583 690 Employee expense 19 19 57 58 Other expenses 71 79 232 254 EBITDA 54 70 -23% 198 247 -20% EBITDA Margin 17% 20% 18% 20% D
Slide 13: About Us
Results Highlights About Us Financial Performance Moving towards Growth Prospects
Slide 14: Amines Industry – Unique but Critical Industry with growth potential
Amines Industry – Unique but Critical Industry with growth potential The size of Aliphatic Amines industry globally The consumable nature of demand and the is $4.9 billion. Globally, the Amine industry is oligopolistic nature of the industry, results in oligopolistic with two-three producers a stron
Slide 15: Balaji Amines Ltd – A Leading player in Aliphatic Amines in India
Balaji Amines Ltd – A Leading player in Aliphatic Amines in India State-of-the-art Forward integrated manufacturing suite of products Largest manufacturer of Aliphatic Amines in facilities fully equipped with latest DCS 40+ Product Downstream products added based on strength of amine manufacturing w
Slide 16: Our Products are supplied to India's fast-growing Industries
Our Products are supplied to India’s fast-growing Industries Industry Wise - Revenue Breakup 3% 4% 3% 4% 3% 2% 4% 51% 26% Pharma Agrochem Paints & Resins Animal Feeds Oil & Gas Rubber Cleaning Chemicals Water Treatment Chemicals Dye and Textiles Others 15
Slide 17: Highly Experienced Management Team
Highly Experienced Management Team Mr. A. Prathap Reddy Mr. D. Ram Reddy Mr. N. Rajeshwar Reddy Mr. A. Srinivas Reddy Executive Chairman Managing Director Whole Time Director Whole Time Director & CFO • 37 years of experience across • Civil Engineer by Education. various businesses. • B. Com. Over 4
Slide 18: Diversified Product Portfolio
Diversified Product Portfolio Particulars Amines Amine Derivatives Specialty & Other Chemicals • Aliphatic Amines find increasing • Amine Derivatives are used to make further consumption and applications in a salts and other complex chemical Intermediates and API’s • Albeit a small and fast growing
Slide 19: Clientele
Clientele Amines Amine Derivatives Specialty & Other Chemicals 18
Slide 20: Well positioned Business Model aimed at Sustainable growth
Well positioned Business Model aimed at Sustainable growth Focus towards high-value derivatives and Develop new indigenous technology for specialty chemicals with an aim to move up manufacturing products leading to lowering in the value-chain with vertical integration manufacturing costs & improving
Slide 21: Key Products (Current & Proposed) in Portfolio
Key Products (Current & Proposed) in Portfolio Product Existing Installed Capacity Proposed Capacity Total Capacity after Application Areas (TPA) (TPA) Expansions (TPA) Methyl Amine 88,000 - 88,000 Pharma, Agro, Dye & Rubber Ethyl Amine 22,500 - 22,500 Pharma, Agro, Dye & Rubber DMAHCL / DMAC 31,000
Slide 22: We are Global suppliers – a significant validation of our Capabilities
We are Global suppliers – a significant validation of our Capabilities • UK • Japan • US • Turkey • Argentina • Finland • Canada • Indonesia • Israel • Switzerland • India • Sri Lanka • Pakistan • Russia • Bangladesh • Malaysia • Oman • Singapore • Germany • Bahrein • Italy • Jordan • Egypt • Guatem
Slide 23: Awards & Certificates – A Testimony of our capabilities
Awards & Certificates – A Testimony of our capabilities ISO Certificate Two Star Export House ISO Certificate BEST CEO (CHEMICAL INDUSTRY) AWARD TO SHRI ANDE PRATHAP REDDY BY BUSINESS TODAY GROUP 02.05.2023 ISO 9001 : 2015 Certificate Certificate of Merit - CHEMEXCIL First Award - CHEMEXCIL WHO GMP
Slide 24: Awards & Certificates – A Testimony of our capabilities
Awards & Certificates – A Testimony of our capabilities Product Innovator of Distinguished Excellent CSR in Water Mahatma Award for “Company of the Year” in International Tourism & the Year in Chemicals Contribution in the Conservation Sustainable and Responsible Chemicals at FICCI Chemicals Hospita
Slide 25: Awards & Recognition - A Testimony of our capabilities
Awards & Recognition - A Testimony of our capabilities On January 28, 2025, Balaji Amines Limited was honored with the “Rasayan Udyog Shri” award by the Indian Chemical Society at its centennial celebration in Mumbai. Chairman Shri A. Pratap Reddy received the award from Prof. G. D. Yadav in the pre
Slide 26: We are Growing…Sustainably and Consistently
We are Growing…Sustainably and Consistently India Ratings Affirms Balaji Amines’ Bank Facilities at ‘IND AA’ “Latest Rating is Non- fund based Facilities INR 1500 Million IND A1+ ; Fund Based Working Capital Facilities INR 1450 Million IND AA / Stable / IND A1+ • Largest manufacturer of aliphatic am
Slide 27: High entry barrier Business – Paving way for Sustainable growth
High entry barrier Business – Paving way for Sustainable growth Complex manufacturing process Niche product offering with high High fixed costs, with fixed asset requiring high levels of lead time in customer approvals turns hovering in the range of 1.5- technological know-how. Efficient 2x. Optimum
Slide 28: Well positioned Business Model aimed at Sustainable growth
Well positioned Business Model aimed at Sustainable growth Value-Added Products Applicability in Solvents segment Capex towards high-value derivatives and specialty chemicals will materialize into higher 01 Solvents account for 80%-90% of the mass utilised in a typical pharmaceutical chemical 05 rev
Slide 29: Greenfield Project to fuel growth and add Revenue Visibility
Greenfield Project to fuel growth and add Revenue Visibility Strategically Project Accorded Product Profile Balaji Specialty Located Plant Mega Project Status Chemicals Environmental In Phase-1 of Greenfield Electronic Grade DMC Electronic Maharashtra’s Energy and Labour clearance received for Proje
Slide 30: Greenfield Project to fuel growth and add Revenue Visibility
Greenfield Project to fuel growth and add Revenue Visibility New Products = First High Demand for Hotel Expansion Solar Power Plant Mover advantage Products Significant The demand of Planning to add 40 new The 20 MW Greenfield Solar opportunity exists to Methylamines has rooms which would Power Plan
Slide 31: About Balaji Speciality Chemicals
About Balaji Speciality Chemicals 01 01 BAL owns 55% in subsidiary Balaji Speciality Chemicals Pvt. Ltd 04 Started exporting products to China, USA, Europe and other which is strategically located at Solapur countries. Have received REACH* registration for EDA, DETA and AEEA. Received Mega project s
Slide 32: R&D led Investments to provide significant early mover advantage
R&D led Investments to provide significant early mover advantage New Products Optimization Integration Continuous efforts to optimize Backward and forward Identification of new products utilization of energy, utilities & integration of products to and development of latest raw materials consumption
Slide 33: About Balaji Sarovar Premiere Hotel
About Balaji Sarovar Premiere Hotel • Commenced Operations in October 2013 Hotel Balaji Sarovar Premier is the only 5 star hotel in Solapur • Invested Rs. 110 crore in the Hotel Project via mix of Debt and Equity • Tied up with Sarovar Group for the Management of the Hotel on Management Fee + Revenu
Slide 34: Balaji Sarovar Premiere – 9MFY25 Operating Matrix
Balaji Sarovar Premiere –9MFY25 Operating Matrix Constitutes 129 Rooms 2.47% of Negligible Routine Capex incurred Rs. 4,957 ARR Total Revenue 69% Rs. 3,437 Occupancy Rate RevPAR Renowned Five Star Hotel In the City of Solapur ARR : Average Room Revenue RevPAR: Revenue per Available Room 33
Slide 35: Financial Performance
Results Highlights About Us Financial Performance Moving towards Growth Prospects
Slide 36: Consolidated Performance Highlights
Consolidated Performance Highlights Revenue (Rs. Crs.) EBITDA (Rs. Crs.) PAT (Rs. Crs.) 2,338 2,371 637 624 418 406 1,671 1,318 379 353 244 232 941 186 97 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 EBITDA Margin (%) PAT Margin (%) RoE (%) 28.8% 27.3% 18.5% 17.9% 31.8%
Slide 37: Strong Core ROCE Profile
Strong Core ROCE Profile Particulars (Rs. Crs.) FY23 FY24 Consolidated Debt 58 20 For FY23, investments made to the tune of Rs. 95.87 crore for Unit 4’s n-Butylamine plant and Methylamine plant and Unit 3’s power Consolidated Networth 1698 1893 plant is not considered, as the operations are work i
Slide 38: Consistent Dividend Payout
Consistent Dividend Payout 550% 500% 300% 200% 140% 160% FY19 FY20 FY21 FY22 FY23 FY24 Particulars (Rs. per share) FY19 FY20 FY21 FY22 FY23 FY24 Consolidated Book Value 183 206 281 406 524 584 Consolidated EPS 36 32 74 114 100 63 Dividend 2.80 3.20 4.00 6.00 10.00 11.00 37
Slide 39: Growth Prospects
Results Highlights About Us Financial Performance Moving towards Growth Prospects
Slide 40: Balaji Amines Ltd - Progressing steadily
Balaji Amines Ltd - Progressing steadily Unit 4: Increased capacity Unit 4 : Improvements at Greenfield projects utilization & capacity Greenfield Capex Phase - 2 & 3 Subsidiary Plant of Subsidiary Plant additions of Phase - 1 capex Investments to be made in various Capex for Phase 2 & 3 of Higher c
Slide 41: ESG & CSR Initiatives
ESG & CSR Initiatives Donated Bus for Punyashlok Ahilyadevi Holkar Solapur Contructed classroom at RR Patil School & Jr College @ Constructed classroom at Baburao Patil Vidhyalay University, Solapur dt. 10.12.2024 Penur, Mohol, Solapur dt 07.06.2024 Gotewadi, Mohol, Solapur dt.09.10.2024 Constructed
Slide 42: ESG & CSR Initiatives
ESG & CSR Initiatives Distributed Sanitary Napkin Incinerator and Vending Machine at Saraswati High Distributed Sanitary Napkin Incinerator and Vending Machine at Saraswati High School, Tamalwadi and Z.P. School, Ghandora dt. 29.02.2024 School, Tamalwadi and Z.P. School, Ghandora dt. 29.02.2024 SSC
Slide 43: ESG & CSR Initiatives
ESG & CSR Initiatives Constructed Toilet Block at Shree Basaveshwar Prashala, Kazikanbas dt 31.01.2024 Contstruction of Toilet Block at Z.P. School, Jalkot dt. 16.01.2024 Constructed kitchen shed at Muk Badhir Niwasi Shala, Mohol dt. 03.01.2024 Constructed classrooms at Saraswati Vidyalay, Tamalwadi
Slide 44: Thank You
For further information, please contact: Company : Balaji Amines Ltd. CIN - L24132MH1988PLC049387 Email - cs@balajiamines.com www.balajiamines.com Investor Relations Advisors : MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services Mr. Bhavya